疼痛医学

以下为当前的临床试验。

按位置、状态和其他条件筛选该研究列表。

1. A Study to Evaluate Analgesic Use and Duration for Pediatric Long Bone Fractures

   Rochester, Minn.

   The purpose of this study is to develop an evidenced-based guideline for pediatric opioid prescribing guideline from the emergency department for long bone fractures to more closely tailor pain management to abuse potential. 

2. A Study to Investigate the Use of Diaphragm Muscle Ultrasound to Assess the Duration of a Diaphragm Nerve Block

   Rochester, Minn.

   The purpose of this study is to to determine the impact of anesthesia (liposomal bupivacaine) on diaphragm muscle forces using a non-invasive ultrasonographic shear wave elastography (SWE) method.  

3. A Study to Evaluate Prevalence of Secondary Adrenal Insufficiency in Patients with Chronic Pain

   Jacksonville, Fla.

   The purpose of this study is to evaluate the hormonal profile related to opioed induced adrenal insufficency (OIAI) in chronic pain patients that completed the 3-weeks Interdisciplinary Pain Rehabilitaion Program (IPRP) at the Pain Rehabilitation Center (PRC) at Mayo Clinic / Florida.

4. Pediatric Pain Rehabilitation Treatment Outcomes for Chronic Noncancer Pain

   Rochester, Minn.

   The purpose of the study is to learn more about adolescent and young adults' experience with chronic pain. In particular, we are studying factors which lead to pain-associated disability and factors which predict decreased disability during and after participation in a three-week intensive treatment program. In addition to gathering information from the young people with chronic pain, parents are also asked to give their perspective.

    

5. Evaluating Patterns of and Changes in Hair Cortisol Levels in Pediatric Patients With Chronic Pain

   Rochester, Minn.

   The purpose of this study is to evaluate patterns of and changes in secretion levels of the stress hormone, cortisol and other steroid hormones (i.e. DHEA, testosterone, progesterone) from hair samples of 150 pediatric patients with chronic pain upon admission and and at 3 and 6 months after participation in Mayo Clinic’s intensive, interdisciplinary pediatric pain treatment program.